| Subgroup | Number of studies |
Summary OR (95 % CI) | Between studies | Between subgroups | |||
|---|---|---|---|---|---|---|---|
| I2 | P heterogeneity | Q | Q | P heterogeneity | |||
|
Gender Female Male Both |
5 5 22 |
1.35 (0.90– 2.01) 1.52 (1.13– 2.05) 1.49 (1.31–1.69) |
70.37 % 0.00 % 59.94 % |
0.01 0.99 0.01 |
14.48 0.27 52.42 | 0.26 | 0.88 |
|
Continents America Asia & Australia Europe |
6 16 9 |
1.45 (0.94–2.25) 1.37 (1.26–1.49) 1.71 (1.47–1.99) |
79.28 % 13.03 % 21.69 % |
0.01 0.30 0.26 |
28.96 20.70 7.66 | 6.38 | 0.04 |
|
Depression Scales BDI CES-D Interview & DSM PHQ-9 Others |
5 2 11 5 8 |
1.52 (1.19–1.94) 1.20 (0.70–2.05) 1.70 (1.37–2.12) 1.49 (1.34–1.66) 1.36 (1.09–1.69) |
0.00 % 76.72 % 50.54 % 67.90 % 0.00 % |
0.88 0.01 0.03 < 0.001 0.44 |
0.25 8.59 20.22 28.03 4.77 | 2.76 | 0.60 |
|
MTs Scales ATP III IDF WHO |
27 4 2 |
1.48 (1.32–1.67) 1.64 (1.39–1.94) 2.00 (0.53–7.52) |
50.56 % 0.00 % 71.85 % |
< 0.001 0.68 0.06 |
52.69 1.51 3.55 | 1.09 | 0.58 |
|
Study Population General Population Patients Other |
27 4 2 |
1.46 (1.33–1.60) 1.95 (1.38–2.74) 0.73 (0.18–2.88) |
35.25 % 58.25 % 89.16 % |
0.04 0.07 < 0.001 |
40.15 7.19 9.22 | 3.54 | 0.17 |
|
Age ≤ 50 Year > 50 Year |
5 7 |
1.66 (1.41–1.94) 1.39 (1.00–1.95) |
42.62 % 50.97 % |
0.14 0.06 |
6.97 12.24 | 0.82 | 0.36 |